- ►diabetesjournals.org MF Carroll, A Izard, K Riboni, MR Burge, DS … - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—The subjects were aged 56 ± 2 years and were moderately obese (BMI 31
± 1 kg/m 2 ), with a mean HbA 1c of 7.4 ± 0.4%. The peak postprandial glucose
excursion above baseline was higher with placebo (6.1 ± 0.5 mmol/l) than ... Cited by 30 - Related articles - BL Direct - All 6 versions
MF Carroll, A Gutierrez, M Castro, D … - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc This study was designed to compare the efficacy of three insulinotropic agents
in the control of postprandial hyperglycemia in type 2 diabetes. Fifteen
subjects with noninsulin-requiring type 2 diabetes were admitted to the ... Cited by 27 - Related articles - BL Direct - All 6 versions
AH Barnett, DM Anderson, S Shelley, R … - Diabetes Obesity and Metabolism, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 14 - Related articles - BL Direct - All 3 versions
- Free from Publisher LS Cozma, SD Luzio, GJ Dunseath, KW … - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—All three drugs were equally effective on the total prandial insulin
secretion (area under the curve [AUC] −15 to 240 min). However, clear
differences were noted in the early insulin secretion (AUC −15 to 30 ... Cited by 37 - Related articles - BL Direct - All 8 versions
- ►aspetjournals.org M Chachin, M Yamada, A Fujita, T Matsuoka, K … - Journal of Pharmacology and Experimental …, 2003 - ASPET A novel antidiabetic agent, nateglinide, is a D-phenylalanine derivative lacking
either a sulfonylurea or benzamido moiety. We examined with the patch-clamp
method the effect of nateglinide on recombinant ATP-sensitive K + (K ATP ) ... Cited by 21 - Related articles - BL Direct - All 3 versions
- ►endojournals.org SD Luzio, DM Anderson, DR Owens - Journal of Clinical Endocrinology & Metabolism, 2001 - Endocrine Soc These studies examined the influence of timing of administration of nateglinide
on the glucose profile and ß-cell secretory response to a standardized test
meal and the effect of meal composition on the pharmacokinetic and ... Cited by 9 - Related articles - BL Direct - All 5 versions
H Abrahamian, M Francesconi, A Loiskandl, A … - Diabetes Technology & Therapeutics, 2004 - liebertonline.com Nateglinide, a new insulinotropic agent, specifically targets prandial glycemic
excursions. Re- cently, innovative technologies have become available that
provide the possibility to measure 72-h blood glucose values continuously. ... Cited by 13 - Related articles - BL Direct - All 3 versions
A Laghmich, L Ladriere, F Malaisse-Lagae, … - Pharmacological Research, 1999 - Elsevier 1. T Yada and S Fujitani, Action mechanisms of a novel hypoglycaemic agent
(A4166) in pancreatic B-cells analyzed by measuring cytosolic Ca concentration.
Diabetes (1992). ... 14. A Sener, F Malaisse-Lagae, SP Dufrane and WJ ... Cited by 14 - Related articles - BL Direct - All 5 versions
